4Kombluth A,Sachar D B.Ulcerative colitis practice guidelines in adults.American college of gastroenterology,practice parameters committee[J].Am J Gastroenterol,1997,92(12):204-211.
5VAN Deventer S J.Targeting TNF-α as a key cyyokine in the inflammatory processes of Crohn's disease-the mechanism of action of infliximab[J].AIiment Phannacol Ther,1999,13(2):45-48.
6Halter A,Schmaddmann B M,Peskar A S,et al.Cyclooxygenase-2 implications on maintenance of gastric mucosal integrity and ulcer healing:Controversial issues and perspectives[J].Gut,2001,49 (12):443-446.
7Tamawski A S,Jones M K.The role of epidermal growth factor (EGF)and its receptor in mucosal protection,adaption to injury and ulcer healing.Involvement of EGF-R signal transduction pathway[J].Clin Gastroenterology,1998,27(12):12-20.
8Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults [J ]. Am J Gastroenterol, 1997,92 : 204 - 211.
9Van Deventer SJH. Targeting TNF - α as a key cytokine in the inflammatory processes of Crohn's disease- The mechanism of action of infliximab[ J ]. Aliment Pharmacol Ther, 1999,13(Suppl) : 43 - 48.
10Halter F, Schmaddmann A, Peskar BM, et al. Cyclooxygenase- 2 implications on maintenance of gastric mucosal integrity and ulcer healing:Controversial issues and perspectives [ J ]. Gut, 2001,49:443 - 453.
